The Immunohistochemistry ($\text{IHC}$) Market involves a critical laboratory technique used in pathology and biomedical research for the selective visualization of antigens (proteins) in tissue sections based on the specific binding of antibodies. This technique is indispensable for diagnosing diseases, particularly cancer, by identifying specific tumor biomarkers that inform prognosis and treatment selection.Immunohistochemistry Market.

Innovation in the market is heavily focused on enhancing workflow efficiency and standardization through Automation. Automated $\text{IHC}$ slide-staining platforms minimize human error, improve reproducibility, and significantly increase the throughput of diagnostic laboratories. Another major trend is the development of Multiplex $\text{IHC}$ techniques, which allow pathologists to simultaneously detect and visualize multiple biomarkers on a single tissue slide. This capability is crucial for the complexity of personalized medicine, where the co-expression of several targets (e.g., $\text{PD}-L1$ and other immune markers) must be assessed to guide targeted or immunotherapies, driving adoption across the